Isomorphic Labs Raises $5 Billion in Series C
Isomorphic Labs secured a $5 billion Series C round co-led by Greenoaks and Sequoia Capital to advance its AI drug-design engine.
Isomorphic Labs has raised $5 billion in a Series C funding round. The round was co-led by Greenoaks and Sequoia Capital, with Andreessen Horowitz participating as a new investor. All existing backers, including Alphabet's venture divisions GV and Capita G, Thrive Capital, MGX, Temasek, and the U.K. Sovereign AI Fund, also participated. This is the company's second mega-round within six months, following a $2.1 billion raise in May 2026. Isomorphic Labs did not disclose its new valuation, though Bloomberg reported earlier that the lab was looking to raise funding at a $50 billion valuation.
The company builds an AI drug-design engine using simulation AI models to explore chemistry areas. Its work builds on DeepMind's AlphaFold protein-folding AI model. Isomorphic Labs reported positive preclinical results in oncology and immunology and has struck deals with pharma giants Eli Lilly, Novartis, and Johnson & Johnson. The company has no approved drug yet. The new funds will be used to develop the drug-design engine and foray into more types of medicine. The money will go toward advancing the in-house platform IsoDDE and pushing the drug pipeline toward clinical trials. IsoDDE aims to better predict drug binding and docking sites and goes beyond AlphaFold 3.
This Series C is Isomorphic's first fundraise since founder and CEO Demis Hassabis left his position at DeepMind. Hassabis moved into a chairman role at DeepMind after leaving the head position. He stepped down from day-to-day leadership of Google DeepMind in August 2026 and now serves as Alphabet's Chief Scientist. Hassabis and John Jumper won the 2024 Nobel Prize in Chemistry for work on AlphaFold. DeepMind's original AlphaFold team was disbanded in July 2026.
Sources
- TechCrunch: AIIsomorphic Labs raises $5B as it looks to take drug candidates to clinical trials ↗
- The DecoderIsomorphic Labs raises $5 billion in its second mega-round within six months ↗
Every sentence of this story was checked against facts quoted from these articles. How we make the news
Spotted an error? Tell us
